The link between Alzheimer’s disease and stroke: A detrimental synergism
Behl, T
Kaur, I
Sehgal, A
Khandige, PS
Imran, M
Gulati, M
Khalid Anwer, M
Elossaily, GM
Ali, N
Wal, P
Gasmi, A
- Publisher:
- Elsevier
- Publication Type:
- Journal Article
- Citation:
- Ageing Research Reviews, 2024, 99, pp. 102388
- Issue Date:
- 2024-08
In Progress
Filename | Description | Size | |||
---|---|---|---|---|---|
1-s2.0-S156816372400206X-main.pdf | Published version | 1.6 MB |
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is being processed and is not currently available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Behl, T | |
dc.contributor.author | Kaur, I | |
dc.contributor.author | Sehgal, A | |
dc.contributor.author | Khandige, PS | |
dc.contributor.author | Imran, M | |
dc.contributor.author | Gulati, M | |
dc.contributor.author | Khalid Anwer, M | |
dc.contributor.author | Elossaily, GM | |
dc.contributor.author | Ali, N | |
dc.contributor.author | Wal, P | |
dc.contributor.author | Gasmi, A | |
dc.date.accessioned | 2025-03-30T07:03:10Z | |
dc.date.available | 2024-05-06 | |
dc.date.available | 2025-03-30T07:03:10Z | |
dc.date.issued | 2024-08 | |
dc.identifier.citation | Ageing Research Reviews, 2024, 99, pp. 102388 | |
dc.identifier.issn | 1568-1637 | |
dc.identifier.issn | 1872-9649 | |
dc.identifier.uri | http://hdl.handle.net/10453/186305 | |
dc.description.abstract | Being age-related disorders, both Alzheimer s disease (AD) and stroke share multiple risk factors, such as hypertension, smoking, diabetes, and apolipoprotein E (APOE) 4 genotype, and coexist in patients. Accumulation of amyloid- plaques and neurofibrillary tangled impair cognitive potential, leading to AD. Blocked blood flow in the neuronal tissues, causes neurodegeneration and cell death in stroke. AD is commonly characterized by cerebral amyloid angiopathy, which significantly elevates the risk of hemorrhagic stroke. Patients with AD and stroke have been both reported to exhibit greater cognitive impairment, followed by multiple pathophysiological mechanisms shared between the two. The manuscript aims to elucidate the relationship between AD and stroke, as well as the common pathways and risk factors while understanding the preventive therapies that might limit the negative impacts of this correlation, with diagnostic modalities and current AD treatments. The authors provide a comprehensive review of the link and aid the healthcare professionals to identify suitable targets and risk factors, that may retard cognitive decline and neurodegeneration in patients. However, more intricate research is required in this regard and an interdisciplinary approach that would target both the vascular and neurodegenerative factors would improve the quality of life in AD patients. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | Elsevier | |
dc.relation.ispartof | Ageing Research Reviews | |
dc.relation.isbasedon | 10.1016/j.arr.2024.102388 | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | 0601 Biochemistry and Cell Biology, 1103 Clinical Sciences, 1109 Neurosciences | |
dc.subject.classification | Gerontology | |
dc.subject.classification | 3101 Biochemistry and cell biology | |
dc.subject.classification | 3202 Clinical sciences | |
dc.subject.classification | 3209 Neurosciences | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Alzheimer Disease | |
dc.subject.mesh | Risk Factors | |
dc.subject.mesh | Stroke | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Alzheimer Disease | |
dc.subject.mesh | Risk Factors | |
dc.subject.mesh | Stroke | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Alzheimer Disease | |
dc.subject.mesh | Risk Factors | |
dc.subject.mesh | Stroke | |
dc.subject.mesh | Animals | |
dc.title | The link between Alzheimer’s disease and stroke: A detrimental synergism | |
dc.type | Journal Article | |
utslib.citation.volume | 99 | |
utslib.location.activity | England | |
utslib.for | 0601 Biochemistry and Cell Biology | |
utslib.for | 1103 Clinical Sciences | |
utslib.for | 1109 Neurosciences | |
pubs.organisational-group | University of Technology Sydney | |
pubs.organisational-group | University of Technology Sydney/Faculty of Health | |
utslib.copyright.status | in_progress | * |
pubs.consider-herdc | true | |
dc.date.updated | 2025-03-30T07:03:07Z | |
pubs.publication-status | Published | |
pubs.volume | 99 |
Abstract:
Being age-related disorders, both Alzheimer s disease (AD) and stroke share multiple risk factors, such as hypertension, smoking, diabetes, and apolipoprotein E (APOE) 4 genotype, and coexist in patients. Accumulation of amyloid- plaques and neurofibrillary tangled impair cognitive potential, leading to AD. Blocked blood flow in the neuronal tissues, causes neurodegeneration and cell death in stroke. AD is commonly characterized by cerebral amyloid angiopathy, which significantly elevates the risk of hemorrhagic stroke. Patients with AD and stroke have been both reported to exhibit greater cognitive impairment, followed by multiple pathophysiological mechanisms shared between the two. The manuscript aims to elucidate the relationship between AD and stroke, as well as the common pathways and risk factors while understanding the preventive therapies that might limit the negative impacts of this correlation, with diagnostic modalities and current AD treatments. The authors provide a comprehensive review of the link and aid the healthcare professionals to identify suitable targets and risk factors, that may retard cognitive decline and neurodegeneration in patients. However, more intricate research is required in this regard and an interdisciplinary approach that would target both the vascular and neurodegenerative factors would improve the quality of life in AD patients.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph